A Phase I Study of ABT-510 in Combination With Bevacizumab in Advanced Solid Tumors

This study has been completed.
Sponsor:
Collaborators:
Genentech, Inc.
Abbott
Information provided by (Responsible Party):
Herbert Hurwitz, Duke University Medical Center
ClinicalTrials.gov Identifier:
NCT00586092
First received: December 21, 2007
Last updated: April 4, 2013
Last verified: April 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2013
  Primary Completion Date: February 2013 (Final data collection date for primary outcome measure)